2nd Day Program
Plenary Session: Clinical Innovation in Patient Centered Care
Moderator: Derek Stewart
Type of Session: Knowledge – Based
Session Program:
Time | Topic |
08:00-08:20 | Impact of Clinician Burnout on Patient Safety: Journey to a Resilient & Thriving Healthcare Workforce
Paul Bush, Pharm.D., M.B.A., BCPS, FASHP Vice President, Global Business Development and Consulting American Society of Health System Pharmacists |
08:20-08:40 | Patient Centered Pharmacy Practice: Clinical Innovation and Shift of Practice
Osama Tabbara, R.Ph, EMBA President, IVPN-Network Pharmacy Consultant | Entrepreneur | Mentor |
08:40-09:00 | A Journey to Zero preventable Harm from Medications
Carolyn Hoffman RN MN, President and CEO Institute for Safe Medication Practices Canada (ISMP Canada) System |
09:00-09:20 | Patient Centered Service Design and Provision
Sherif Kamal RPh,MSc, DHCM Pharmacy Programs Director, Children Cancer Hospital .Egypt |
09:20-09:40 | Discussion |
09:40-11:00 | Coffee Break |
Parallel Session: Patient Safety in Oman: Achievements and Breakthrough
Moderator: Ibrahim AlRashdi
Type of Session: Knowledge – Based
Session Program:
Time | Topic |
11:00-11:15 | Analysis of adverse drug reactions due to covid-19 vaccine at a tertiary care hospital (SQUH) in Oman
Alsayyida Bushra Albusaidi, senior pharmacist SQUH, Muscat |
11:15- 11:30 | Safe practice influenced by clinical pharmacist co-led anti coagulation clinic
Nadiya Albulushi, Specialized pharmacist, DGQAC, MOH, Oman |
11:30-11:45 | Poison Prevention & Patient Safety “The Role of Poisoning Centres”
Badria Alhatali, MD,FACMT Head of Poison Control Section, Department of Environmental and Occupational Health, Directorate General of Disease Surveillance and Control. Ministry of Health. Emergency Medicine Consultant at Royal Hospital Middle East and North Africa Clinical Toxicology Association (MENATOX)president |
11:45-12:00 | Cost and Clinical Implication of Clinical Pharmacist Interactions on Antimicrobial Use at Sultan Qaboos Hospital
Bushra Al-lawati, Clinical Pharmacist, Sultan Qaboos university Hospital, Oman |
12:00-12:15 | Sohar Hospital Patient Safety Improvement Process” pharmacy Prospective”
Ahmed AlZaabi, Clinical pharmacist, Sohar Hospital ,Oman |
12:15-12:30 | Discussion |
12:30-12:45 | Incidence of Dementia and Alzheimer’s in Elderly Patients
Shireen Alzidjali, Clinical Pharmacist, Sultan Qaboos university Hospital, Oman |
12:45-13:00 | Managing Poly-Pharmacy Prescription in Al Masarra Hospital
Isra Al Lawati, clinical pharmacist, DGMS, Oman |
13:00-13:15 | Development & Implementation of Strategic Frameworks for Polypharmacy Management in Health Care Organizations
Sara Al-balushi, Sr. Specialist Pharmacist Director pharmaceutical Care. MOH.Oman |
13:15-13:30 | Building a Patient Safety Savvy Pharmacist Workforce in Oman: Academic Institutions Play a leading Role
Jimmy Jose, Associate Professor of pharmacy Practice, school of pharmacy, University of Nizwa. Oman |
13:30-13:45 | Survey Based Study on Medication Reconciliation at Tertiary Care Hospital in Muscat
Yumna Jadallah, College of Pharmacy National University of Science and technology. Oman |
13:45-14:00 | Optimizing Safe Utilization of Covid-19 Medication in the Royal Hospital
Umkulthum Salim Albarwani, senior specialized pharmacist, MSc in clinical pharmacy MPharm Head of National Heart center pharmacy |
14:00 –14:10 | Discussion |
14:00-15:00 | Lunch and Prayer Break |
Parallel Session: ASHP Program Expanding Clinical Pharmacy Services
Moderator: Charles Daniels
Type of Session: Knowledge – Based
Session Program:
Time | Topic |
11:00-11:20 | Building and Expanding Clinical Pharmacy Services
Paul Bush, Pharm.D., M.B.A., BCPS, FASHP Vice President, Global Business Development and Consulting American Society of Health System Pharmacists |
11:20- 11:40 | ASHP Vision for Pharmacy Workforce in Hospitals and Health Systems
Anna Legreid Dopp, PharmD, CPHQ Senior Director, Clinical Guidelines and Quality Improvement, ASHP |
11:40-12:00 | Developing Pharmacist Competencies for Clinical and Specialty Pharmacy
Paul W. Bush, PharmD, MBA, BCPS, FASHP Vice President, Global Resource Development and Consulting, ASHP |
12:00-12:20 | The Safety of Intravenous Drug Delivery Systems: Update on Issues Since the 2009 Consensus Development Conference
John Hertig, PharmD, MS, CPPS, FASHP Associate Professor and Vice-Chair of Pharmacy Practice Butler University College of Pharmacy and Health Sciences |
12:20-12:30 | Discussion |
Parallel Session: Therapeutic Advances and Disease Management
Moderator: Osama Tabara
Type of Session: Knowledge – Based
Session Program:
Time | Topic |
12:30-12:45 | Cardio – oncology challenges in the era of novel therapies
Nora Al-khudair, BScPharm, PharmD, Assistant Professor of Clinical Pharmacy College of Pharmacy ,King Saud University Hematology, Oncology and SCT Clinical Pharmacist at KSUMC,KSA |
12:45-13:00 | New Antibiotics for MDR Gram-negative pathogens
Khalid Eljaaly, PharmD, MS, BCPS, BCIDP Associate Professor and Consultant Infectious Disease Pharmacist at King Abdulaziz University, and Chairman of Infectious Disease PSN of Saudi Society of Clinical Pharmacy, KSA. |
13:00-13:15 | Drug Resistant Epilepsy- Medical Management
Haifa Al-Abri, MD, Consultant Adult Neurology /Epilepsy and Neurophysiology , Sultan Qaboos University Hospital ,Oman |
13:15-13:25 | TPN in Neonates and Pediatrics: Optimizing Therapy and Preventing Complication
Faisal A. AlSehli, BSc, MSc, HSQM, PharmD Department of Clinical Pharmacy King Abdulaziz Medical City. KSA |
13:25-13:30 | Discussion |
14:00-15:00 | CLOSING CEREMONY |
15:00-16:00 | Lunch |